Page last updated: 2024-08-21

chenodeoxycholic acid and Carcinoma, Pancreatic Ductal

chenodeoxycholic acid has been researched along with Carcinoma, Pancreatic Ductal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bergmann, F; Fortunato, F; Gonzalez, FJ; Hackert, T; Heger, U; Hinz, U; Huang, Z; Loos, M; Sun, H; Xu, Z; Zhang, Y1
Argent, BE; Carr, G; Gray, MA; Hasegawa, M; Hegyi, P; Ignáth, I; Inoue, M; Rakonczay, Z; Székely, CA; Takács, T; Venglovecz, V1

Other Studies

2 other study(ies) available for chenodeoxycholic acid and Carcinoma, Pancreatic Ductal

ArticleYear
Farnesoid X receptor activation inhibits pancreatic carcinogenesis.
    Biochimica et biophysica acta. Molecular basis of disease, 2023, Volume: 1869, Issue:7

    Topics: Animals; Bile Acids and Salts; Carcinogenesis; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Chenodeoxycholic Acid; Humans; Mice; Pancreas; Pancreatic Neoplasms

2023
CFTR expression but not Cl- transport is involved in the stimulatory effect of bile acids on apical Cl-/HCO3- exchange activity in human pancreatic duct cells.
    Pancreas, 2009, Volume: 38, Issue:8

    Topics: Animals; Bicarbonates; Biological Transport; Calcium; Calcium Signaling; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cells, Cultured; Chenodeoxycholic Acid; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Mutation; Pancreatic Ducts; Pancreatic Neoplasms; Transfection

2009